apoC-I Double Nickase Plasmid (m): sc-419163-NIC
- Target species: mouse
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- apoC-I Double Nickase Plasmid (m) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- apoC-I Double Nickase Plasmid (m) and apoC-I Double Nickase Plasmid (m2) encode distinct paired gRNA designs targeting Apoc1. One or both designs may be available
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
apoC-I Double Nickase Plasmid (m) | sc-419163-NIC | 20 µg | $410.00 | |||
apoC-I Double Nickase Plasmid (m2) | sc-419163-NIC-2 | 20 µg | $410.00 |
Apolipoprotein C-I (apoC-I), encoded by the mouse Apoc1 gene, is a small secreted apolipoprotein enriched on triglyceride-rich lipoproteins and HDL that modulates plasma lipid transport and clearance. It influences lipoprotein remodeling and receptor-mediated uptake by regulating lipase activity and interactions with hepatic receptors, linking Apoc1 to pathways governing triglyceride metabolism, cholesterol trafficking, and systemic energy balance. In macrophages and other myeloid compartments, Apoc1 expression is associated with lipid handling programs and inflammatory signaling networks that shape foam-cell biology. Dysregulated apoC-I levels or Apoc1 locus activity has been studied in the context of metabolic dysfunction and atherosclerosis-related processes, supporting mechanistic research into lipid-driven inflammation.
apoC-I Double Nickase Plasmid (m) consists of a matched pair of plasmids engineered for high-specificity editing of the Apoc1 locus in mouse cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within Apoc1. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt Apoc1 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of Apoc1-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.